Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats

Circulation Journal

Volumn 78, Issue 9, 2014, Pages 2284-2291

  Aoki, Yuji ^a   Kai, Hisashi ^a   Kudo, Hiroshi ^a   Takayama, Narimasa ^a   Yasuoka, Suguru ^a   Anegawa, Takahiro ^a   Iwamoto, Yoshiko ^a   Uchiwa, Hiroki ^a   Fukuda, Kenji ^a   Fukumoto, Yoshihiro ^a   Imaizumi, Tsutomu ^a,e   Kajimoto, Hidemi ^b   Kage, Masayoshi ^c   Kato, Seiya ^d  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KURUME UNIVERSITY HOSPITAL   (Japan)

^d SAISEIKAI FUKUOKA GENERAL HOSPITAL   (Japan)

^e INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Angiotensin; Blood pressure variability; Hypertension; Kidney; Remodeling

Indexed keywords

CANDESARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERIOLOSCLEROSIS; ARTICLE; BILATERAL SINOAORTIC DENERVATION; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; CORTICAL SCLEROTIC LESION; DENERVATION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; NONHUMAN; RAT; RENAL PARENCHYMAL LESION; ANIMAL; ARTERIOSCLEROSIS; BLOOD PRESSURE; ISCHEMIA; KIDNEY CORTEX; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION;

ANIMALS; ARTERIOSCLEROSIS; BLOOD PRESSURE; HYPERTENSION; ISCHEMIA; KIDNEY CORTEX; RABBITS; RATS, INBRED SHR;

EID: 84906819179     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0027     Document Type: Article

References (33)

1. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96-104.
2. Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988; 11: 273-281.
3. Canonico V, De Caprio L, Vigorito C, Forgione L, Tedeschi C, Guarini P, et al. Differences in blood pressure profile between young and elderly hypertensive patients. J Hum Hypertens 1990; 4: 405-409.
4. Kai H, Kaneyuki M, Shihara M, Toyama Y, Mitsutake Y, Umei H, et al. Reduction in morning blood pressure is a key factor for ameliorating urinary albumin excretion in patients with morning hypertension irrespective of treatment regimen. Circ J 2013; 77: 1551-1557.
5. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of targetorgan damage in hypertension. J Hypertens 1987; 5: 93-98.
6. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992; 152: 1855-1860.
7. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variablity. J Hypertens 1993; 11: 1133-1137.
8. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000; 102: 1536-1541.
9. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al. Relation between blood pressure variability and carotid artery damage in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19: 1981-1989.
10. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood pressure variability and organ damage in a general population: Results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39: 710-714.
11. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45: 505-512.
12. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. Awake systolic blood pressure variability correlates with targetorgan damage in hypertensive subjects. Hypertension 2007; 50: 325-332.
13. Kawai T, Ohishi M, Kamide K, Onishi M, Takeya Y, Tatara Y, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res 2012; 35: 239-243.
14. Yokota K, Fukuda M, Matsui Y, Hoshide S, Shimada K, Kario K. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013; 36: 151-157.
15. Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, et al. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II systemmediated chronic inflammation. Hypertension 2009; 54: 832-838.
16. Kai H, Kudo H, Takayama N, Yasuoka S, Kajimoto H, Imaizumi T. Large blood pressure variability and hypertensive cardiac remodeling: Role of cardiac inflammation. Circ J 2009; 73: 2198-2203.
17. Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis 1995; 25: 207-221.
18. Takayama N, Kai H, Kudo H, Yasuoka S, Mori T, Anegawa T, et al. Simvastatin prevents large blood pressure variability-induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways. Hypertens Res 2011; 34: 341-347.
19. Yasuoka S, Kai H, Kajimoto H, Kudo H, Takayama N, Anegawa T, et al. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats. Circ J 2013; 77: 1274-1281.
20. Seki Y, Kai H, Shibata R, Nagata T, Yasukawa H, Yoshimura A, et al. Roles of JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 2000; 87: 12-18.
21. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130-135.
22. Kai H, Kuwahara F, Tokuda K, Shibata R, Kusaba K, Niiyama H, et al. Coexistence of hypercholesterolemia and hypertension impairs adventitial vascularization. Hypertension 2002; 39: 455-459.
23. Kuwahara F, Kai H, Tokuda K, Niiyama H, Tahara N, Kusaba K, et al. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 2003; 41: 819-823.
24. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, et al. Hypertensive myocardial fibrosis and diastolic dysfunction: Another model of inflammation. Hypertension 2004; 43: 739-745.
25. Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, et al. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2004; 43: 499-503.
26. Tahara N, Kai H, Niiyama H, Mori T, Sugi Y, Takayama N, et al. Repeated gene transfers of naked prostacyclin synthase plasmid into skeletal muscles attenuate monocrotaline-induced pulmonary hypertension and prolong survival in rats. Human Gene Ther 2004; 15: 1270-1278.
27. Takemiya K, Kai H, Yasukawa H, Tahara N, Imaizumi T. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats. Basic Res Cardiol 2010; 105: 409-417.
28. Mori T, Kai H, Kajimoto H, Koga M, Kudo H, Takayama N, et al. Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: A possible mechanism of diastolic dysfunction in postmenopausal women. Hypertens Res 2011; 34: 496-502.
29. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: A viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 2009; 32: 115-121.
30. Matsuda H, Hayashi K, Arakawa K, Naitoh M, Kubota E, Honda M, et al. Zonal heterogeneity in action of angiotensin-converting enzyme inhibitor on renal microcirculation: Role of intrarenal bradykinin. JASN 1999; 10: 2272-2282.
31. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-1930.
32. Ogawa S, Nako K, Okamura M, Senda M, Sakamoto T, Abe T, et al. A decline in glomerular filtration rate rather than renal arterial stenotic lesions, per se, predicts cardiovascular-renal events in type 2 diabetic patients. Circ J 2013; 77: 2816-2822.
33. Ikeda A, Kai H, Kajimoto H, Yasuoka S, Kage M, Imaizumi T. Selective gene expression analysis of muscular and vascular components in hearts using laser microdissection method. Int J Vasc Med 2012; 2012: 863410, doi:10.1155/2012/863410.